Citigroup
INBX icon

Citigroup’s Inhibrx INBX Stock Holding History

Citigroup’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.17M Buy
75,721
+13,205
+21% +$1.32M ﹤0.01% 1851
2026
Q1 		$4.2M Buy
62,516
+6,757
+12% +$501K ﹤0.01% 2099
2025
Q4 		$4.4M Buy
55,759
+50,788
+1,022% +$3.46M ﹤0.01% 2105
2025
Q3 		$167K Buy
4,971
+1,639
+49% +$40.4K ﹤0.01% 4062
2025
Q2 		$47.5K Sell
3,332
-5,177
-61% -$66.9K ﹤0.01% 4784
2025
Q1 		$119K Sell
8,509
-1,464
-15% -$19.9K ﹤0.01% 4497
2024
Q4 		$154K Buy
9,973
+673
+7% +$10.3K ﹤0.01% 4592
2024
Q3 		$146K Buy
9,300
+5,108
+122% +$71.8K ﹤0.01% 4570
2024
Q2 		$59.4K Buy
+4,192
New +$65.5K ﹤0.01% 4485

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citigroup's INBX Position: Q2 2026 in Review

Citigroup increased its Inhibrx (INBX) stake by 21% in Q2 2026, buying an estimated $1.32M and bringing the position to 75,721 shares worth $7.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1851.

Citigroup first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Citigroup held 75,721 shares of Inhibrx worth $7.17M as of Q2 2026.
  • Citigroup bought 13,205 Inhibrx shares in Q2 2026, an estimated $1.32M.
  • Inhibrx made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1851 holding.
  • Citigroup first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.